RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)
Clinical trial NCT02801097 · TERMINATED
Trial details
- NCT number
- NCT02801097
- Sponsor
- EpicentRx, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2018-11-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.